David Haylock

David Haylock

Company: VivaZome Therapeutics

Job title: CEO

Seminars:

PANEL DISCUSSION: Comparing Engineered & Naturally Derived Exosomes for Therapeutic Benefit 11:45 am

Is engineering exosomes even necessary? Comparing across disease indications Strategies to test the capacity of both What are the advantages of engineering exosomes as therapeutics and as drug delivery vehicles? Linking engineering to the successful loading of cargo Regulatory considerations of engineering exosomes at scaleRead more

day: Day One

Live Presenter Q&A 10:15 am

Ask the speakers your most burning questions!Read more

day: Day One

Selecting Preferred Cells for Engineering Exosomes 9:25 am

Different cells produce exosomes with different microRNA signatures Can the microRNA profile inform clinical use? Enhancing angiogenic potential by microRNA knockdownRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.